Acura Pharmaceuticals Inc. – Credit Agreements Watch

EX-10.70

from 10-K ~5 pages Amended Loan Schedule to Secured Promissory Note Dated November 10, 2022 Between Acura Pharmaceuticals, Inc and Abuse Deterrent Pharma, LLC ​

12/34/56

EX-10.37

from 10-Q 4 pages Fourth Amendment to Loan and Security Agreement

12/34/56

EX-10.2

from 10-Q 13 pages Consent and Third Amendment to Loan and Security Agreement

12/34/56

EX-10.6

from S-1 4 pages Consent and Second Amendment to Loan and Security Agreement

12/34/56

EX-10.8

from 10-K 16 pages First Amendment to Loan and Security Agreement

12/34/56

EX-10.6

from 10-K 57 pages Loan and Security Agreement

12/34/56

EX-10.1

from 8-K 6 pages Sixth Amendment, Waiver and Consent to Loan Agreement

12/34/56

EX-10.2

from 8-K 6 pages Fifth Amendment, Waiver and Consent to Loan Agreement

12/34/56

EX-10.1

from 8-K 5 pages Fourth Amendment, Waiver and Consent to Loan Agreement

12/34/56

EX-10.1

from 8-K 55 pages Loan Agreement

12/34/56

EX-10.2

from 8-K 54 pages Loan Agreement

12/34/56

EX-10.1

from 8-K 40 pages Loan Agreement

12/34/56

EX-10.1

from 8-K 41 pages Loan Agreement

12/34/56

EX-10.13

from 8-K ~10 pages Third Amendment to Loan Agreement

12/34/56

EX-10.11

from 8-K ~5 pages Second Amendment to Loan Agreement

12/34/56

EX-10.58

from 8-K 1 page Amendment to Loan Agreement

12/34/56

EX-10.57

from 8-K ~50 pages Material contract

12/34/56

EX-10.45

from 10-K ~50 pages A/R and Consolidated Bridge Loan Agreement

12/34/56